Your search returned 15 results.

Results
	1.	Immunodeficiency and cancer: prospects for correction. [electronic resource] by Hadden, John W Producer: 20040329 In: International immunopharmacology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy. [electronic resource] by Naylor, Paul H Hadden, John W Producer: 20100701 In: Annals of the New York Academy of Sciences vol. 1194 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Protection by methyl inosine monophosphate (MIMP) against aerosol influenza virus infection in mice. [electronic resource] by Masihi, K Noel Hadden, John W Producer: 20021224 In: International immunopharmacology vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	T cell immunostimulation by methyl inosine 5'-monophosphate: application to infectious diseases. [electronic resource] by Signorelli, Kathy L Hadden, John W Producer: 20040329 In: International immunopharmacology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	T cell targeted immune enhancement yields effective T cell adjuvants. [electronic resource] by Naylor, Paul H Hadden, John W Producer: 20040329 In: International immunopharmacology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Immunopharmacology of thymosin alpha1 and cytokine synergy. [electronic resource] by Naylor, Paul H Quadrini, Karen Garaci, Enrico Rasi, Guido Hadden, John W Producer: 20071227 In: Annals of the New York Academy of Sciences vol. 1112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2. [electronic resource] by Meneses, Abelardo Verastegui, Emma Barrera, Jose L de la Garza, Jaime Hadden, John W Producer: 20040329 In: International immunopharmacology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Long-term immune dysfunction after radiotherapy to the head and neck area. [electronic resource] by Verastegui, Emma L Morales, Rocio B Barrera-Franco, Jose L Poitevin, Adela C Hadden, John Producer: 20040329 In: International immunopharmacology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic. [electronic resource] by Czystowska, Malgorzata Szczepanski, Miroslaw J Szajnik, Marta Quadrini, Karen Brandwein, Harvey Hadden, John W Whiteside, Theresa L Producer: 20110518 In: Cancer immunology, immunotherapy : CII vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro. [electronic resource] by Egan, James E Quadrini, Karen J Santiago-Schwarz, Frances Hadden, John W Brandwein, Harvey J Signorelli, Kathy L Producer: 20070924 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck. [electronic resource] by Freeman, Scott M Franco, Jose Luis Barrera Kenady, Daniel E Baltzer, Lorraine Roth, Zygmund Brandwein, Harvey J Hadden, John W Producer: 20110602 In: American journal of clinical oncology vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	IRX-2 increases the T cell-specific immune response to protein/peptide vaccines. [electronic resource] by Naylor, Paul H Hernandez, Karla E Nixon, April E Brandwein, Harvey J Haas, Gabriel P Wang, Ching Y Hadden, John W Producer: 20101230 In: Vaccine vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	A short course of neoadjuvant IRX-2 induces changes in peripheral blood lymphocyte subsets of patients with head and neck squamous cell carcinoma. [electronic resource] by Whiteside, Theresa L Butterfield, Lisa H Naylor, Paul H Egan, James E Hadden, John W Baltzer, Lorraine Wolf, Gregory T Berinstein, Neil L Producer: 20120820 In: Cancer immunology, immunotherapy : CII vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen. [electronic resource] by Berinstein, Neil L Wolf, Gregory T Naylor, Paul H Baltzer, Lorraine Egan, James E Brandwein, Harvey J Whiteside, Theresa L Goldstein, Lynn C El-Naggar, Adel Badoual, Cecile Fridman, Wolf-Herve White, J Michael Hadden, John W Producer: 20120820 In: Cancer immunology, immunotherapy : CII vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer. [electronic resource] by Wolf, Gregory T Fee, Willard E Dolan, Robert W Moyer, Jeffrey S Kaplan, Michael J Spring, Paul M Suen, James Kenady, Daniel E Newman, Jason G Carroll, William R Gillespie, M Boyd Freeman, Scott M Baltzer, Lorraine Kirkley, Terry D Brandwein, Harvey J Hadden, John W Producer: 20120325 In: Head & neck vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)